SMAD3 and renal fibrosis: Since CDDP and DFO interventions did not affect apoptosis, these findings suggest that ferroptosis is a potential target for treatments aimed at delaying renal fibrosis progression, and that the TGF-β1/Smad3 signaling pathway is important in this context.